Comerica Bank lessened its stake in shares of Xylem Inc. (NYSE:XYL - Free Report) by 8.8% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 36,432 shares of the industrial products company's stock after selling 3,503 shares during the quarter. Comerica Bank's holdings in Xylem were worth $4,352,000 at the end of the most recent reporting period.
Other hedge funds have also added to or reduced their stakes in the company. Valley National Advisers Inc. grew its holdings in Xylem by 84.9% during the 1st quarter. Valley National Advisers Inc. now owns 220 shares of the industrial products company's stock valued at $26,000 after buying an additional 101 shares in the last quarter. Perkins Coie Trust Co bought a new stake in shares of Xylem during the 1st quarter valued at about $27,000. Center for Financial Planning Inc. boosted its position in shares of Xylem by 52.0% during the 1st quarter. Center for Financial Planning Inc. now owns 266 shares of the industrial products company's stock valued at $32,000 after acquiring an additional 91 shares during the last quarter. Heck Capital Advisors LLC bought a new stake in shares of Xylem during the 4th quarter valued at about $36,000. Finally, Headlands Technologies LLC boosted its position in shares of Xylem by 90.6% during the 1st quarter. Headlands Technologies LLC now owns 305 shares of the industrial products company's stock valued at $36,000 after acquiring an additional 145 shares during the last quarter. Hedge funds and other institutional investors own 87.96% of the company's stock.
Xylem Trading Up 1.5%
XYL stock traded up $2.14 during midday trading on Thursday, hitting $141.84. The company had a trading volume of 806,322 shares, compared to its average volume of 1,002,033. The company has a current ratio of 1.90, a quick ratio of 1.43 and a debt-to-equity ratio of 0.17. Xylem Inc. has a 52 week low of $100.47 and a 52 week high of $145.33. The stock's 50 day moving average price is $137.11 and its 200 day moving average price is $127.17. The stock has a market cap of $34.52 billion, a price-to-earnings ratio of 36.84, a PEG ratio of 2.42 and a beta of 1.09.
Xylem (NYSE:XYL - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The industrial products company reported $1.26 earnings per share for the quarter, beating the consensus estimate of $1.15 by $0.11. Xylem had a return on equity of 10.33% and a net margin of 10.74%.The firm had revenue of $2.30 billion during the quarter, compared to the consensus estimate of $2.20 billion. During the same quarter in the previous year, the company posted $1.09 earnings per share. The business's revenue was up 6.1% on a year-over-year basis. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. As a group, equities research analysts expect that Xylem Inc. will post 4.65 earnings per share for the current fiscal year.
Xylem Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 25th. Shareholders of record on Thursday, August 28th will be given a $0.40 dividend. The ex-dividend date is Thursday, August 28th. This represents a $1.60 annualized dividend and a yield of 1.1%. Xylem's payout ratio is presently 41.56%.
Wall Street Analyst Weigh In
A number of analysts have recently issued reports on the company. Cowen reiterated a "hold" rating on shares of Xylem in a research report on Tuesday, August 26th. TD Cowen lifted their price target on Xylem from $125.00 to $130.00 and gave the company a "hold" rating in a research report on Tuesday, August 26th. UBS Group lifted their price target on Xylem from $164.00 to $168.00 and gave the company a "buy" rating in a research report on Tuesday, August 5th. Citigroup restated a "buy" rating and issued a $152.00 target price (up previously from $137.00) on shares of Xylem in a research report on Monday, July 14th. Finally, Raymond James Financial upgraded Xylem to a "hold" rating in a research report on Thursday, May 15th. Six equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Xylem currently has a consensus rating of "Moderate Buy" and a consensus price target of $152.29.
Read Our Latest Research Report on Xylem
About Xylem
(
Free Report)
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Featured Articles

Before you consider Xylem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.
While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.